ReviewAntibiotics (Basel, Switzerland)2020

Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of

Mahmoud Ghannoum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.